Bioceres Crop Solutions Reports Q1 2026 Earnings
Bioceres Crop Solutions reported Q1 2026 earnings with $77.5 million in revenue, a 17% decline from last year due to strategic shifts. Despite this, gross profit rose to $36.2 million with a 47% margin. Operating profit increased to $7.1 million, but net loss widened to $7.5 million due to higher costs. Adjusted EBITDA grew 61% to $13.6 million. The company aims to enhance revenue quality and financial flexibility for long-term resilience.
Bioceres Crop Solutions ( (BIOX) ) has released its Q1 earnings. Here is a breakdown of the information Bioceres Crop Solutions presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Bioceres Crop Solutions Corp. is a company focused on developing and commercializing agricultural productivity solutions that enhance crop resilience to climate change, operating primarily in the biotechnology sector. In its fiscal first quarter of 2026, Bioceres reported total revenues of $77.5 million, marking a 17% decline from the previous year, largely due to strategic shifts in its business model. Despite the revenue decline, the company achieved a gross profit of $36.2 million with an improved gross margin of 47%, up from 40% the previous year, indicating a more profitable product mix. Operating profit increased significantly to $7.1 million, while the net loss widened to $7.5 million due to higher financial costs and tax accruals. Adjusted EBITDA saw a substantial increase of 61% to $13.6 million, driven by cost discipline and margin expansion. Looking ahead, Bioceres’ management remains focused on enhancing revenue quality, protecting margins, and improving financial flexibility, positioning the company for long-term resilience in a challenging market environment.
